Stryker Earnings, Revenue Miss in Q2

This post was originally published on this site

Stryker announced earnings per share of $2.25 on revenue of $4.49B. Analysts polled by Investing.com anticipated EPS of $2.28 on revenue of $4.54B.

Stryker shares are down 14% from the beginning of the year, still down 27.30% from its 52 week high of $281.16 set on September 9, 2021. They are outperforming the Euro Stoxx 50 which is down 16.82% from the start of the year.

Stryker shares gained 1.51% in after-hours trade following the report.

Stryker’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.

J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar